News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Degussa Biotech Spin-Out Elbion AG Nets 25 Milllon Euros


10/19/2005 5:12:04 PM

LONDON, Jan 10 (Reuters) - Elbion AG, a privately owned biotechnology firm spun off by German chemicals group Degussa AG (DGXG.DE: Quote, Profile, Research) , has raised 25 million euros ($33 million) in a first round of venture capital funding, it said on Monday.

Read at Reuters

Related News

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES